Skip to content
Search

Latest Stories

BMA calls on pharmacists to support campaign against 2024/25 GP contract changes

BMA calls on pharmacists to support campaign against 2024/25 GP contract changes

The Chair of GPC England at the BMA has written to Wes Streeting detailing how they can work together to rebuild general practice in England

BMA campaign against GP contract changes

The British Medical Association (BMA) has urged non-GP partners and contractors, including pharmacists, nurses, and physiotherapists, to support their “Protect Your Patients, Protect Your GP Practice” campaign, which was launched to protest changes to the 2024/25 GP contract.


GP contractors and partners across England have strongly opposed the modifications to the GMS contract, leading to an ongoing dispute with the NHS.

The BMA highlights that general practice in England currently receives just 6 pence of every NHS pound and an average GMS 'global sum' of £107.57 per registered patient annually.

Since 2018/19, CPI erosion to the GMS contract has resulted in a loss of £659 million, or 6.6%. This financial strain has contributed to the closure or merger of over 1,300 practices over the past decade.

To address these issues, the BMA is urging all GP contractors and partner members to vote YES in the GPC England non-statutory ballot, which will be open until July 29.

They have also created a form for non-GP partners and contractors to sign in support of the campaign.

Through this campaign, the BMA aims to prompt the government to re-engage in negotiations with the General Practitioners Committee England (GPCE) in good faith to deliver a new contract that provides the investment needed to transform, rebuild, and reinvigorate general practice.

The BMA envisions a new "2025 Family Doctor Charter" with a commitment to allocate up to 15 per cent of NHS expenditure towards primary medical services to restore general practice as “the jewel in the NHS crown” and protect services, patient confidence, and NHS productivity.

Katie Bramall-Stainer, Chair of GPC England at the BMA, has written to the new Secretary of State for Health and Social Care, Wes Streeting, detailing how they can work together to rebuild general practice in England.

“General practice is at a crisis point, funding for essential bread and butter practice services has been severely eroded, and our contract uplifts have been derisory,” said Katie Bramall-Stainer.

In the letter to Wes Streeting, she highlighted the closure of more than 2,000 GP practices over the past 14 years and the loss of over 5,000 'home-grown' GPs, whose training has cost taxpayers between £2-3 billion.

Additionally, the number of registered patients has surged by 6.4 million in the past five years, leading to an 18 per cent increase in the average number of patients per full-time equivalent fully qualified GP, now exceeding 2,300.

“We intend to develop a constructive relationship with the new government, but will remain organised to ensure GPs can secure the contract that patients and staff deserve,” the BMA noted.

The Association has also shared their vision for the future of general practice with the Secretary of State.

The ongoing ballot is intended to build momentum for planned collective action, which will commence on August 1.

“This will not be strike action. Services will not be withdrawn in this initial phase of the campaign, and contracts will not be breached. However, the impact on NHS England and ICB (integrated care board) budgets will be felt keenly,” the BMA said.

GPCE emphasised that the outgoing Government pledged to honour the 2024/25 Doctors’ and Dentists’ Review Body (DDRB) uplift in July 2024, but NHS England and the Department of Health and Social Care (DHSC) provided only a 1.9% interim uplift in April 2024, resulting in a real-terms cut in funding.

According to the BMA DDRB Swingometer, even if the newly elected Government were to more than quadruple this uplift, which the GPCE thinks is highly unlikely, practices will still be facing a huge shortfall compared with 2018/19.

“Funding hasn’t just stood still for the past five and a half years or so; it has reduced in value in terms of what it can pay for on behalf of patients,” it said.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less